CRI
ALT icon

Commonwealth Retirement Investments’s Altimmune ALT Stock Holding History

Commonwealth Retirement Investments’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$4 – 133
2025
Q4 		$4 Buy
+1
New +$4 ﹤0.01% 432

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Commonwealth Retirement Investments's ALT Position: Q1 2026 in Review

Commonwealth Retirement Investments sold out of Altimmune (ALT) in Q1 2026, closing a stake of 1 share — an estimated $4 sold.

Commonwealth Retirement Investments first reported a position in ALT in Q4 2025 and held it in 1 quarter. The position peaked at $4 in Q4 2025. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Commonwealth Retirement Investments reported no remaining Altimmune position as of Q1 2026 after selling out during the quarter.
  • Commonwealth Retirement Investments sold 1 Altimmune share in Q1 2026, an estimated $4.
  • Commonwealth Retirement Investments first reported a position in Altimmune in Q4 2025 and held it in 1 quarter.
  • Commonwealth Retirement Investments's Altimmune position peaked at $4 in Q4 2025.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Commonwealth Retirement Investments's 13F filing for Q1 2026, filed 11 May 2026.